Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeFUNDINGMojo Vision Raises Additional $51 Million+ in Series B-1 Round

Mojo Vision Raises Additional $51 Million+ in Series B-1 Round

Funding to be Used for the Development of First True Smart Contact Lens

Mojo Vision, the Invisible Computing company, today announced it has raised more than $51 million in a Series B-1 investment round to propel the development of the first true smart contact lens, Mojo Lens.

This new round brings Mojo Vision’s total funding to date to more than $159 million.

Mojo Vision’s latest round of funding was led by New Enterprise Associates (NEA) with participation from top strategic investors and venture firms, including Gradient Ventures, Khosla Ventures, Liberty Global Ventures, Struck Capital, Dolby Family Ventures, Motorola Solutions Venture Capital, Fusion Fund, Intellectus Partners, KDDI Open Innovation Fund, Numbase Group, InFocus Capital Partners, and others.

Mojo also announced that Greg Papadopoulos, Ph.D., venture partner at NEA, will join its board of directors. Papadopoulos and NEA co-led the seed round in Mojo Vision along with CEO and co-founder Drew Perkins.

Papadopoulos has more than 30 years of experience in the technology industry and academia. Prior to NEA, Papadopoulos was EVP and CTO of Sun Microsystems and before Sun, he was an associate professor of EECS at the Massachusetts Institute of Technology (MIT). He has also helped found a number of companies and was an engineer with HP and Honeywell. Papadopoulos is a relentless advocate for diversity in engineering and a supporter of open development models that stimulate communication, inclusiveness, and innovation.

In January, Mojo announced that it is in the process of building the world’s first true smart contact lens, called Mojo Lens. Mojo Lens is a contact lens with a built-in display that is designed to give people useful and timely information without forcing them to look down at a screen or lose focus on the people and the world around them. Mojo calls this eyes-up experience Invisible Computing, a platform that enables information to be instantaneous, unobtrusive, and available hands-free, allowing people to interact with each other more freely and genuinely.

“The unveiling of the details of our product development earlier this year has generated increased excitement and momentum around the potential of Mojo Lens,” said Perkins. “This new round of funding brings more support and capital from strategic investors and companies to help us continue our breakthrough technology development. It gets us closer to bringing the benefits of Mojo Lens to people with vision impairments, to enterprises and eventually, consumers.”

The company is planning an early application of Mojo Lens to help people who live with vision impairment. By using enhanced image overlays, this application is designed to serve as a visual aid, providing real-time contrast and scene enhancement that will make navigation, obstacle avoidance, and personal interactions easier. Mojo is actively working with the U.S. Food and Drug Administration (FDA) through its Breakthrough Devices Program, a voluntary program designed to provide safe and timely access to medical devices that can help treat irreversibly debilitating diseases or conditions.

“NEA has been with Mojo since the beginning, sharing the vision to build and bring to market the first true smart contact lens,” said Papadopoulos. “The potential applications of this innovative technology could fundamentally change the way we work and view our world, as well as improve the quality of life for people with vision impairment. This is a tremendously exciting opportunity and I’m humbled to be joining the board of directors and to continue partnering with the talented team at Mojo.”

Mojo Lens is currently in the research and development phase and is not available for sale anywhere in the world.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy